Prinivil Articles
Scientists show that BP drug lisinopril could have value in treating multiple sclerosis
19 August 2009
Dr Reddy's to commercialize two Torrent drugs in Russia
11 December 2006
Wal-Mart's $4 generics offer spreads to 15 US states on "considerable" public demand
30 October 2006
NHS "wasting L500M on drugs" claim
1 May 2006
USA
22 August 2005
AstraZeneca's EPS up 56%, sales rise 10%
1 November 2004
Generics slowed rising Rx costs in 2003: PBM
14 June 2004
AstraZeneca forecasts sharp rise in earnings but shares slip on mediocre Crestor sales
9 February 2004
AstraZeneca 4th-qtr results lower, but in line with expectations
2 February 2004
Generics "can be dearer in Canada than USA"
26 January 2004
AstraZeneca raises full-year earnings guidance
28 July 2003
New generic moves from Michigan Blues
12 May 2003
Gedeon Richter sees product mix improve in 2002
21 April 2003
AstraZeneca to issue earnings warning?
3 February 2003
AstraZeneca sales rise 6.9% in 2nd quarter
5 August 2002
AstraZeneca forecasts growth in Spain
25 March 2002
Hypertension market set for major change.
21 January 2002
Provisional US approval for Ranbaxy antihypertensive.
21 January 2002
Hypertension market prospects to 2010
13 December 2001
Merck & Co issues profit warning
12 December 2001
Lisinopril products get patent reprieve in USA
27 November 2001
Ranbaxy aiming for wider Indian market share
29 October 2001
AstraZeneca sales rise 8%, Nexium doing well
26 July 2001
AstraZeneca hit by slip in Losec sales
26 April 2001
Teva gets tentative OK for generic Prinivil
24 April 2001
US HMOs reveal their most-accepted drugs
5 April 2001
AstraZeneca issues sales and profits slowdown warning
8 February 2001
AstraZeneca hits Indian snag
2 January 2001
Ranbaxy cardiac drug launch in USA sees brisk sales
7 September 2000
Modest 1st qtr for Richter Gedeon
8 May 2000
AstraZeneca sees 17% 1st qtr pretax growth
3 May 2000
B-MS' Vanlev "more effective" than lisinopril
23 March 2000
Pfizer's Cardura "no better" than diuretic
16 March 2000
AstraZeneca full-year profits up 20% as new products come good
24 February 2000
Stock Commentary New York
17 February 2000
First approval for B-MS' Tequin heats up antibiotic sector - update
30 December 1999
B-MS to file for Vanlev approval by year-end
11 November 1999
Gensia Sicor gets court backing for propofol
16 August 1999
Positive 1st-qtr news from AstraZeneca
26 May 1999
US filing for high-dose lisinopril in CHF
6 April 1999
Zeneca shows confidence on Astra merger; reports good 1998 results
17 February 1999
Merck disappointment as highly-touted antidepressant stalls
26 January 1999
More approvals for Zestril for diabetes
21 January 1999
Zeneca to Pursue 6 mth Zestril exclusivity in US
7 January 1999
AstraZeneca's Effect On Rest Of Pharma Sector
17 December 1998
GW, SB Lining Up Offers For Zeneca?
15 December 1998
Astra & Zeneca Join In Euro Merger Mania
10 December 1998
Astra & Zeneca Join In Euro Merger Mania
9 December 1998
Zeneca's Zestril "Most Prescribed ACE Inhibitor In USA"
2 December 1998
Nolvadex Approval Puts Zeneca On A High
19 November 1998
Strong Earnings Growth For Indian Pharma Groups
2 November 1998
Zeneca Pharma Sales High But Disappoints Overall
29 October 1998
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
Zeneca Profits Decline, But Underlying Growth Strong
6 August 1998
US Drug Stocks Plummet After Merck Disappoints
23 July 1998
UK Pharma Leaders Outline Strategy
22 June 1998
ATLAS Trial Mandates High ACEI Doses In CHF
8 April 1998
Stock Commentary Europe
2 April 1998
Good Earnings Growth At Zeneca Despite Strong L
5 March 1998
Zeneca Diprivan Patent Extension, New Zestril Indication
5 February 1998
Pharma Sector Boosts Zeneca 1997 Performance
28 January 1998
Broker Upgrades Zeneca On Acquisition And New Product Outlook
13 January 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
Zeneca Allays Fears Of Near-Term Product Gap
4 December 1997
Zeneca Sees Strong Growth Against The Odds
8 August 1997
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
